Aster DM Quality CareNSE:ASTERDM -0.21%80 Return-on-Tangible-Equity is 13.08% as of Mar. 2026, which is 15% below its 10-year median of 15.45. GuruFocus rates NSE:ASTERDM with a GF Score™ of 80/100 and a GF Value™ of ₹660.21 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 579 Healthcare Providers & Services companies, Aster DM Quality Care ranks worse than 50.43% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Aster DM Quality Care's annualized net income for the quarter that ended in Mar. 2026 was ₹5,607 Mil. Aster DM Quality Care's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹42,855 Mil. Therefore, Aster DM Quality Care's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 13.08%.
The historical rank and industry rank for Aster DM Quality Care's Return-on-Tangible-Equity or its related term are showing as below:
NSE:ASTERDM'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.6 Med: 15.45 Max: 145.39
Current: 9.99
During the past 12 years, Aster DM Quality Care's highest Return-on-Tangible-Equity was 145.39%. The lowest was 3.60%. And the median was 15.45%.
NSE:ASTERDM's Return-on-Tangible-Equity is ranked worse than 50.43% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs NSE:ASTERDM: 9.99
Aster DM Quality Care (NSE:ASTERDM) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Aster DM Quality Care Return-on-Tangible-Equity Related Terms
Aster DM Quality Care Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Aster DM Quality Care's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aster DM Quality Care Return-on-Tangible-Equity Chart
NSE:ASTERDM vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.08% mean?
Aster DM Quality Care (NSE:ASTERDM) has a Return-on-Tangible-Equity of 13.08% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aster DM Quality Care and its competitors. This is 15% below median its historical median of 15.45. Over the past decade, Aster DM Quality Care's Return-on-Tangible-Equity has ranged from 3.60 to 145.39. According to the industry distribution chart, Aster DM Quality Care ranks #292 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 50.4%.
Is Aster DM Quality Care's Return-on-Tangible-Equity too high?
Aster DM Quality Care's current Return-on-Tangible-Equity of 13.08% is 15% below median its 10-year median of 15.45. Over the past 10 years, this metric has ranged from a low of 3.60 to a high of 145.39. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Aster DM Quality Care's value of 13.08% is 29.1% above this industry median. Based on the distribution chart, Aster DM Quality Care ranks #292 out of 579 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Aster DM Quality Care has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #292 out of 579 companies for Return-on-Tangible-Equity. This places Aster DM Quality Care in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.13. Aster DM Quality Care's value of 13.08% is 29.1% above this benchmark. Historically, Aster DM Quality Care's own Return-on-Tangible-Equity has ranged from 3.60 to 145.39 over the past decade. While the company's 10-year median is 15.45 vs. the industry median of 10.13, Aster DM Quality Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aster DM Quality Care's current Return-on-Tangible-Equity of 13.08% is 29.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aster DM Quality Care and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current Return-on-Tangible-Equity is 13.08%, which is 15% below median its own 10-year median of 15.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹660.21, compared to a current price of ₹791.55 — trading 19.9% above its estimated fair value. The current Return-on-Tangible-Equity is 13.08%, which is 15% below median its 10-year median of 15.45 and 29.1% above the Healthcare Providers & Services industry median of 10.13. Aster DM Quality Care's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current Return-on-Tangible-Equity is 13.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹791.55 is trading 19.9% above its estimated GF Value™ of ₹660.21.
GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.
Key valuation signals for NSE:ASTERDM:
Return-on-Tangible-Equity: 13.08% (15% below median its 10-year median of 15.45)
GF Value™: ₹660.21 vs. price of ₹791.55 (19.9% above fair value)
Industry Position: 29.1% above the Healthcare Providers & Services median (#292 of 579)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
80GF Score
Get the complete analysis for NSE:ASTERDM
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 
